Pacira reported $580.49M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Astellas Pharma JPY 831.43B 83.94B Mar/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 52.25B 15.62B Mar/2025
Ligand Pharmaceuticals USD 24K 0 Mar/2025
Novo Nordisk 118.72B 61.75B Mar/2025
Pacira USD 580.49M 2.88M Jun/2025
Perrigo USD 3.65B 24.4M Jun/2025
Pfizer USD 60.93B 1.18B Jun/2025
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025
Teva Pharmaceutical Industries USD 17.52B 872M Jun/2025
Xeris Pharmaceuticals USD 257.22M 10.01M Jun/2025
Zoetis USD 6.79B 214M Jun/2025